Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK3117391 in severe active rheumatoid arthritis
NCT02965599Phase 2Terminated
- Sponsor
- GSK
- Start
- Dec 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of GSK3117391 in rheumatoid arthritis (RA), sponsored by GSK. Started Dec 2016; status: terminated.
02
Drugs
GSK3117391
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02965599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02965599.